Appetite Satisfaction and Short-term Satiety of Different Plant Compositions in the Adolescent Age Group

Sponsor
Laboratorios Ordesa (Industry)
Overall Status
Completed
CT.gov ID
NCT04067466
Collaborator
(none)
20
1
2
17.2
1.2

Study Details

Study Description

Brief Summary

This study evaluates the satiating effect of two types of food supplements made from various types of fibres in the subsequent intake of other foods, in satiety, and in the regulation of hormones

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Fiber product
  • Dietary Supplement: Control product
N/A

Detailed Description

This study assessing the effect on appetite satisfaction and short-term satiety of different plant compositions in the adolescent age segment wants to assess the satiating effect of two types of food supplements made with various types of fibers (inulin, maltodextrins, guar gum and dehydrated plums) in the subsequent intake of other foods, in satiety, and in the regulation of hormones (ghrelin, leptin and insulin) and other peptides involved in the mechanisms of satiety

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effect on Appetite Satisfaction and Short-term Satiety of Different Plant Compositions in the Adolescent Age Group
Actual Study Start Date :
Jul 26, 2017
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fiber product

Fiber product: Inulin, maltodextrin, gum guar, plum powder

Dietary Supplement: Fiber product
Fiber product with inulin, maltodextrin, gum guar and plum powder.

Placebo Comparator: Control product

Maltodextrin, plum powder

Dietary Supplement: Control product
Placebo product with maltodextrin and plum powder

Outcome Measures

Primary Outcome Measures

  1. Assessment of satiety using objective methods (blood analysis) [Change from week 1 to week 2]

    Biochemistry : glucose, urea, BUN, creatinin (all in mg/dL)

  2. Assessment of satiety (blood analysis) [Change from week 1 to week 2]

    Biochemistry : GOT and GPT (UI/L)

  3. Assessment of satiety using a subjective method (visual analogue scale) [Change from week 1 to week 2]

    The perceived feeling of satiety will be measured using the 100mm "Visual Analogue Scale" labeled at a far end with a "mark" to the left of "extremely hungry", and on the other with an "extremely satiated"."

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women between 15 and 30 years old.

  • Subjects with IMC<25 kg/m2

  • Subjects who have a habit of having breakfast, lunch and dinner every day

  • Subjects who are willing to comply with the study procedures

Exclusion Criteria:
  • Subjects taht are taking any medicines that affect the appetite or food intake

  • Presence of endocrine-metabolic diseases

  • Eating disorders

  • Subjects who are following a special diet

  • Subjects who have changed their body weight by more than 10% in the last three months prior to the study

  • Subjects who follow a restrictive dietary pattern such as vegetarians, gluten-free diets, weight loss diets, etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 GENUD Research Group, Universidad de Zaragoza Zaragoza Aragón Spain 50009

Sponsors and Collaborators

  • Laboratorios Ordesa

Investigators

  • Principal Investigator: Luis Moreno Aznar, Universidad de Zaragoza

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laboratorios Ordesa
ClinicalTrials.gov Identifier:
NCT04067466
Other Study ID Numbers:
  • VEGYDOWN-15 (B)
First Posted:
Aug 26, 2019
Last Update Posted:
Aug 26, 2019
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 26, 2019